AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26632698 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified mini-surgical percutaneous dilatational tracheostomy (msPDT)
Number of subjects: 360
Study 26632698 — intervention group
Group type: COMPARATOR
Intervention: Surgical tracheostomy (ST)
Number of subjects: 360
Study 23768465 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracycline chemotherapy
Number of subjects: 39
Study 21219598 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid genetic counseling and testing (RGCT)
Number of subjects: 255
Study 21219598 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 255
Study 19901877 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-layer compression system
Number of subjects: 24
Study 19901877 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-stretch compression system
Number of subjects: 24
Study 19901877 — intervention group
Group type: COMPARATOR
Intervention: Four-layer compression system
Number of subjects: 24
Study 16777690 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan (130 mg/m2 IV over 90 minutes) and Docetaxel (50 mg/m2 IV over 60 minutes) on Day 1 q3 weeks for 6 cycles
Number of subjects: 46
Study 16777690 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan and Docetaxel
Number of subjects: 46
Study 15577128 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene at a dosage of 60 or 120 mg/day for 3 years
Number of subjects: 7705
Study 15577128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7705
Study 10989959 — intervention group
Group type: COMPARATOR
Intervention: 4 mg 17beta-estradiol valerate (E2)
Number of subjects: 20
Study 10989959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9288377 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam-flumazenil
Number of subjects: 40
Study 9288377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 8245345 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A - second balloon inflation at a higher level than the first
Number of subjects: 48
Study 8245345 — intervention group
Group type: COMPARATOR
Intervention: Group B - first two inflations at the same level of balloon pressure
Number of subjects: 48
Study 3828253 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous oestrogen-norethisterone acetate
Number of subjects: 44
Study 3828253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 31421989 — intervention group
Group type: EXPERIMENTAL
Intervention: HDM SLIT tablets for 4 weeks followed by dual therapy with JCP SLIT tablets for 8 weeks
Number of subjects: 109
Study 31421989 — intervention group
Group type: EXPERIMENTAL
Intervention: JCP SLIT tablets for 4 weeks followed by dual therapy with HDM SLIT tablets for 8 weeks
Number of subjects: 109
Study 31421989 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy with both SLIT tablets administered within 5 min after 4 weeks of monotherapy
Number of subjects: 109
Study 29788827 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based education
Number of subjects: 225
Study 29788827 — intervention group
Group type: COMPARATOR
Intervention: Nurse-led education
Number of subjects: 225
Study 28330808 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib (4-weeks-on/2-weeks-off schedule)
Number of subjects: 202
Study 28330808 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib (continuous daily dosing schedule)
Number of subjects: 202
Study 28330808 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib (all patients)
Number of subjects: 202
Study 25660590 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser (G1)
Number of subjects: 163
Study 25660590 — intervention group
Group type: COMPARATOR
Intervention: QMR scalpel (G2)
Number of subjects: 163
Study 25660590 — intervention group
Group type: COMPARATOR
Intervention: Cold blade (G3)
Number of subjects: 163
Study 23357837 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-mg pregabalin capsule
Number of subjects: 12
Study 23357837 — intervention group
Group type: COMPARATOR
Intervention: 100-mg pregabalin solution (capsule dissolved in water)
Number of subjects: 12
Study 23357837 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of both interventions
Number of subjects: 12
Study 21192149 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimonabant (20 mg/d)
Number of subjects: 15
Study 21192149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 18629368 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination strategy (perindopril/indapamide 2 mg/0.625 mg, with possible increase to 3 mg/0.935 mg, and 4 mg/1.250 mg if needed)
Number of subjects: 329
Study 18629368 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential monotherapy approach (atenolol 50 mg, followed by losartan 50 mg and amlodipine 5 mg if needed)
Number of subjects: 329
Study 18629368 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped-care strategy (valsartan 40 mg, followed by valsartan 80 mg and valsartan 80 mg + hydrochlorothiazide 12.5 mg if needed)
Number of subjects: 329
Study 16613215 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol (500 mg/day)
Number of subjects: 246
Study 16613215 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg/day)
Number of subjects: 246
Study 16613215 — intervention group
Group type: COMPARATOR
Intervention: Diet alone (Control)
Number of subjects: 246
Study 16613215 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy (including probucol and pravastatin)
Number of subjects: 246
Study 12621389 — intervention group
Group type: EXPERIMENTAL
Intervention: Telithromycin (800 mg daily, repeated doses)
Number of subjects: 34
Study 12621389 — intervention group
Group type: EXPERIMENTAL
Intervention: Telithromycin (800 mg, single dose)
Number of subjects: 34
Study 12621389 — intervention group
Group type: EXPERIMENTAL
Intervention: Telithromycin (1600 mg, single dose)
Number of subjects: 34
Study 12621389 — intervention group
Group type: EXPERIMENTAL
Intervention: Telithromycin (2400 mg, single dose)
Number of subjects: 34
Study 12621389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 10562690 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 102
Study 10562690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 10562690 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 102
Study 10562690 — intervention group
Group type: EXPERIMENTAL
Intervention: BID fractionation
Number of subjects: 102
Study 10562690 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor KPS
Number of subjects: 102
Study 8692511 — intervention group
Group type: EXPERIMENTAL
Intervention: Burch procedure
Number of subjects: 77
Study 8692511 — intervention group
Group type: EXPERIMENTAL
Intervention: Sling procedure
Number of subjects: 77
Study 8692511 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 77
Study 1768158 — intervention group
Group type: EXPERIMENTAL
Intervention: Folinic acid
Number of subjects: 27
Study 1768158 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 6890700 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 15
Study 6890700 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 15
Study 6890700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 6890700 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch from placebo to active medication
Number of subjects: 15
Study 6890700 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-dependent changes
Number of subjects: 15
Study 31773873 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselor-initiated (CI) adaptation of the Look AHEAD intensive lifestyle intervention
Number of subjects: 248
Study 31773873 — intervention group
Group type: COMPARATOR
Intervention: Self-paced (SP) adaptation
Number of subjects: 248
Study 30764769 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for 7 days
Number of subjects: 249
Study 30764769 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for 14 days
Number of subjects: 249
Study 30764769 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT)
Number of subjects: 249
Study 30764769 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-regional proadrenomedullin (MR-proADM)
Number of subjects: 249
Study 30764769 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP)
Number of subjects: 249
Study 30764769 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT concentrations
Number of subjects: 249
Study 30764769 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-proADM levels
Number of subjects: 249
Study 30764769 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP
Number of subjects: 249
Study 29717175 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger capsules
Number of subjects: 178
Study 29717175 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 178
Study 26983390 — intervention group
Group type: EXPERIMENTAL
Intervention: UC-MSC treatment (0.5-1.0×10(6) cells/kg/month for 3 months)
Number of subjects: 180
Study 26983390 — intervention group
Group type: COMPARATOR
Intervention: Standard medical treatment only (control group)
Number of subjects: 180
Study 24513025 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (30 mg)
Number of subjects: 27
Study 24513025 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (60 mg)
Number of subjects: 27
Study 24513025 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (30 mg)
Number of subjects: 27
Study 24513025 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 22951360 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling intervention
Number of subjects: 37
Study 20853930 — intervention group
Group type: EXPERIMENTAL
Intervention: Practicing small acts of self-control for 2 weeks before quitting smoking
Number of subjects: 122
Study 20853930 — intervention group
Group type: COMPARATOR
Intervention: Practicing a task that increased awareness of self-control or feelings of confidence
Number of subjects: 122
Study 17492904 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 0
Study 17492904 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin
Number of subjects: 0
Study 11008278 — intervention group
Group type: EXPERIMENTAL
Intervention: Balneophysical treatments (process expectation)
Number of subjects: 248
Study 11008278 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocational counselling (process expectation)
Number of subjects: 248
Study 11008278 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of complaints (outcome expectation)
Number of subjects: 248
Study 11008278 — intervention group
Group type: EXPERIMENTAL
Intervention: Ability for work (outcome expectation)
Number of subjects: 248
Study 11008278 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall expectations
Number of subjects: 248
Study 11008278 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional status correlation
Number of subjects: 248
Study 11008278 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional distress correlation
Number of subjects: 248
Study 11008278 — intervention group
Group type: EXPERIMENTAL
Intervention: Locus of control correlation
Number of subjects: 248
Study 9182387 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 800 micrograms/day
Number of subjects: 13
Study 9182387 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate 800 micrograms/day
Number of subjects: 13
Study 8456526 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Doppler imaging (CDI) and angiography in hypertensive cases
Number of subjects: 60
Study 8456526 — intervention group
Group type: COMPARATOR
Intervention: Color Doppler imaging (CDI) and angiography in normotensive cases
Number of subjects: 60
Study 3510687 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam
Number of subjects: 27
Study 3510687 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 28285432 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine colostrum (BC) 3.2 g/day
Number of subjects: 18
Study 28285432 — intervention group
Group type: COMPARATOR
Intervention: Whey protein (WP) 3.2 g/day
Number of subjects: 18
Study 27452603 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle-induced weight loss program (supervision via telemonitoring)
Number of subjects: 74
Study 27452603 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 74
Study 24742126 — intervention group
Group type: EXPERIMENTAL
Intervention: Pole walking program (Exerstrider method), 12 weeks, 3 sessions per week, building from 20 to 30 minutes
Number of subjects: 60
Study 24742126 — intervention group
Group type: COMPARATOR
Intervention: Walking program, 12 weeks, 3 sessions per week, building from 20 to 30 minutes
Number of subjects: 60
Study 24742126 — intervention group
Group type: EXPERIMENTAL
Intervention: Pole walking program
Number of subjects: 60
Study 24742126 — intervention group
Group type: COMPARATOR
Intervention: Walking program
Number of subjects: 60
Study 23613788 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried Blood Spot (DBS) sampling for HBsAg detection
Number of subjects: 200
Study 23613788 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried Blood Spot (DBS) sampling for anti-HBs detection
Number of subjects: 200
Study 23613788 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried Blood Spot (DBS) sampling for HBV DNA detection
Number of subjects: 200
Study 23613788 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried Blood Spot (DBS) sampling for HBeAg detection
Number of subjects: 200
Study 23613788 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried Blood Spot (DBS) sampling for HBV genotyping and mutation detection
Number of subjects: 200
Study 19949417 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise protocol for bowel management (BM)
Number of subjects: 68
Study 19949417 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 68
Study 19065892 — intervention group
Group type: EXPERIMENTAL
Intervention: PTS (Protoparaxotril Saporlirs)
Number of subjects: 140
Study 19065892 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 140
Study 19065892 — intervention group
Group type: EXPERIMENTAL
Intervention: PTS plus Aspirin
Number of subjects: 140
Study 19065892 — intervention group
Group type: COMPARATOR
Intervention: Control group D (no aspirin)
Number of subjects: 140
Study 16469469 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard education and additional computer-based education (n=82)
Number of subjects: 154
Study 16469469 — intervention group
Group type: COMPARATOR
Intervention: Standard education (n=72)
Number of subjects: 154
Study 12477757 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg twice daily + Amoxicillin 1 g twice daily
Number of subjects: 181
Study 12477757 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg once daily
Number of subjects: 181
Study 10923593 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylbutazone
Number of subjects: 1
Study 10923593 — intervention group
Group type: EXPERIMENTAL
Intervention: Metamizole
Number of subjects: 1
Study 10923593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 8829556 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 0.4 mg/kg bolus followed by continuous infusion 0.4 mg/kg/h
Number of subjects: 0
Study 8829556 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 0.1, 0.2, and 0.3 mg/kg bolus followed by continuous infusion of 0.1, 0.2, and 0.3 mg/kg/h
Number of subjects: 0
Study 8829556 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal application of 100 mg indomethacin
Number of subjects: 0
Study 1520111 — intervention group
Group type: EXPERIMENTAL
Intervention: Molteno group
Number of subjects: 40
Study 1520111 — intervention group
Group type: COMPARATOR
Intervention: ACTSEB group
Number of subjects: 40
Study 29053981 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright Light Therapy (BLT)
Number of subjects: 74
Study 29053981 — intervention group
Group type: COMPARATOR
Intervention: Dim Red Light Therapy (dRLT)
Number of subjects: 74
Study 29927211 — intervention group
Group type: EXPERIMENTAL
Intervention: Pursed-lips breathing exercise (PBE)
Number of subjects: 54
Study 29927211 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragmatic breathing exercise (DBE)
Number of subjects: 54
Study 29927211 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 54
Study 24555508 — intervention group
Group type: EXPERIMENTAL
Intervention: Priority setting with patient involvement
Number of subjects: 172
Study 24555508 — intervention group
Group type: COMPARATOR
Intervention: No patient involvement
Number of subjects: 172
Study 22310655 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional exercise for deep cervical flexor training, performed for two weeks.
Number of subjects: 20
Study 22310655 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 20
Study 20149361 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist ganirelix
Number of subjects: 0
Study 19145731 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-beta-1a 44 microg
Number of subjects: 0
Study 19145731 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-beta-1a 66 microg
Number of subjects: 0
Study 19145731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15923802 — intervention group
Group type: EXPERIMENTAL
Intervention: Tandem transplants (T)
Number of subjects: 60
Study 15923802 — intervention group
Group type: COMPARATOR
Intervention: Single high-dose chemotherapy (S)
Number of subjects: 60
Study 12791629 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried formula milk intake in infancy (measured in oz)
Number of subjects: 679
Study 10988090 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous tracheal gas insufflation (CTGI)
Number of subjects: 34
Study 10988090 — intervention group
Group type: COMPARATOR
Intervention: Non-CTGI
Number of subjects: 34
Study 8871021 — intervention group
Group type: EXPERIMENTAL
Intervention: Class II amalgam restorations
Number of subjects: 1213
Study 1514556 — intervention group
Group type: EXPERIMENTAL
Intervention: Meconium aspirator at -150 mm Hg with continuous suction
Number of subjects: 14
Study 1514556 — intervention group
Group type: EXPERIMENTAL
Intervention: Meconium aspirator at -80 mm Hg with continuous suction
Number of subjects: 14
Study 1514556 — intervention group
Group type: EXPERIMENTAL
Intervention: Meconium aspirator at -40 mm Hg with continuous suction
Number of subjects: 14
Study 1514556 — intervention group
Group type: EXPERIMENTAL
Intervention: 10F suction catheter at -150 mm Hg with continuous suction
Number of subjects: 14
Study 1514556 — intervention group
Group type: EXPERIMENTAL
Intervention: 10F suction catheter at -80 mm Hg with continuous suction
Number of subjects: 14
Study 1514556 — intervention group
Group type: EXPERIMENTAL
Intervention: 10F suction catheter at -40 mm Hg with continuous suction
Number of subjects: 14
Study 1514556 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand pump with one activation
Number of subjects: 14
Study 1514556 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand pump with two activations
Number of subjects: 14
Study 1514556 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous suction
Number of subjects: 14
Study 1514556 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing suction pressure
Number of subjects: 14
Study 6480458 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro-03-8799 at 1 g/m2
Number of subjects: 9
Study 6480458 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro-03-8799
Number of subjects: 9
Study 30580130 — intervention group
Group type: EXPERIMENTAL
Intervention: CSL112 6 g
Number of subjects: 83
Study 30580130 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 30577848 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cycling and speed of processing training for 6 months
Number of subjects: 128
Study 30577848 — intervention group
Group type: COMPARATOR
Intervention: Cycling only for 6 months
Number of subjects: 128
Study 30577848 — intervention group
Group type: COMPARATOR
Intervention: Speed of processing only for 6 months
Number of subjects: 128
Study 30577848 — intervention group
Group type: COMPARATOR
Intervention: Attention control for 6 months
Number of subjects: 128
Study 30577848 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 128
Study 29771017 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal corticosteroids combined with normal saline nasal irrigation
Number of subjects: 273
Study 29771017 — intervention group
Group type: COMPARATOR
Intervention: Intranasal corticosteroids only
Number of subjects: 273
Study 29771017 — intervention group
Group type: COMPARATOR
Intervention: Intranasal corticosteroids combined with antihistamines
Number of subjects: 273
Study 24727364 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT-AN)
Number of subjects: 63
Study 24727364 — intervention group
Group type: COMPARATOR
Intervention: Specialist supportive clinical management (SSCM)
Number of subjects: 63
Study 22086310 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 599
Study 22086310 — intervention group
Group type: COMPARATOR
Intervention: Alendronate
Number of subjects: 599
Study 19773728 — intervention group
Group type: COMPARATOR
Intervention: Transurethral Microwave Therapy (TUMT)
Number of subjects: 0
Study 19773728 — intervention group
Group type: COMPARATOR
Intervention: Transurethral Needle Ablation (TUNA)
Number of subjects: 0
Study 19773728 — intervention group
Group type: COMPARATOR
Intervention: Holmium Laser Therapy
Number of subjects: 0
Study 19773728 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral Ethanol Ablation of Prostate (TEAP)
Number of subjects: 0
Study 19773728 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensity Frequency Ultrasound (HIFU)
Number of subjects: 0
Study 19773728 — intervention group
Group type: COMPARATOR
Intervention: Minimally Invasive Surgical Techniques (MISTs)
Number of subjects: 0